Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Where's the news?

Valid point. I expect that from now through the end of the year we will see licenses increase, as well as news regarding changes to PDSG that affect the company's public face, an increase in PDSG related contracts, and perhaps other notable developments in the PDSG product line. Anyone remember the Company's comment regarding filing patents for improvements to the CDX platform? I wonder what these will bring to the table?

Cheers,

DG

Share
New Message
Please login to post a reply